Almirall S.A. (ALM.MC) — Quality & forensics
As of 2026-11-16 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 65
- Quality 45
- Growth 64
- Balance sheet 57
- Cash quality 66
- Capital allocation 34
- Momentum 44
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the ALM.MC chart & overview
FAQ · from the current data · as of 2026-11-16
Quick answers
What is Almirall S.A.'s Closelooknet quality reading?
The composite reads 55/100 across 7 modules, as of 2026-11-16: valuation 65, quality 45, growth 64, balance sheet 57, cash quality 66, capital allocation 34, momentum 44. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Almirall S.A.'s Altman Z-Score?
2.46, which sits in the grey zone (1.81–2.99) as of 2026-11-16. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Almirall S.A.'s Piotroski F-Score?
6 of 9, as of 2026-11-16. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Almirall S.A.'s Beneish M-Score indicate?
-2.08 — below the −1.78 manipulation-risk threshold, as of 2026-11-16. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- IRWD Ironwood Pharmaceuticals Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- GALDY GALDERMA GROUP AGindustry
- BHC.TO Bausch Health Companies Incindustry
- XERS Xeris Pharmaceuticals Incindustry
- HLUN-B.CO H Lundbeck A/Sindustry
- PCRX Pacira BioSciences, Inc.industry
- ETON Eton Pharmaceuticals Incindustry
- VTRS Viatris Incindustry
- ELAN Elanco Animal Healthindustry
- RDY Dr. Reddy’s Laboratories Ltd ADRindustry
- AMPH Amphastar Pindustry
- NBIX Neurocrine Biosciences Incindustry
- VETO.PA Vetoquinolindustry
- GUD.TO Knight Therapeutics Inc.industry
- UTHR United Therapeutics Corporationindustry
- 000538.SHE Yunnan Baiyao Group Co Ltdindustry
- FAE.MC Faes Farma SAindustry